Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Oct 26 2023

Full Issue

Advisers Say High-Risk Men Should Get Mpox Shots Even After Outbreak

Government health experts advised the CDC director that gay and bisexual men at high risk for mpox infection should get vaccinated after the current outbreak comes to an end. Among other news, an anti-mask mandate passes in the Senate; Texas' House approves a ban on covid shot mandates; more.

AP: Mpox Vaccinations Should Be Recommended For High-Risk Men, Even After Outbreak Ends, Advisers Say

Gay and bisexual men at high risk for mpox infection should get vaccinated for the virus even after the current outbreak ends, government health advisers said Wednesday. The committee’s recommendation now goes to the director to the Centers for Disease Control and Prevention and — if she signs off on it — is sent out as guidance to U.S. doctors. (Stobbe, 10/25)

On the spread of covid-19 —

The (Cleveland) Plain Dealer: JD Vance’s Anti-Mask Amendment Passes The U.S. Senate 

The U.S. Senate on Wednesday approved a proposal introduced by Ohio’s JD Vance that would block the Department of Transportation from using any federal money to enforce mask mandates in response to COVID-19 through the current fiscal year. The Cincinnati Republican’s amendment to a transportation spending bill was approved by a 59 to 38 margin. (Eaton, 10/25)

The Texas Tribune: Texas House Approves Ban On COVID-19 Vaccine Mandates By Private Employers 

After several attempts by Republicans to rein in COVID-19 vaccine mandates by Texas employers, lawmakers are edging closer to a statewide ban on the practice after legislation won House approval Wednesday. Violators would be subject to a whopping $50,000 fine under an amendment adopted Wednesday by the Texas House. The bill’s sponsor called it the strongest such ban in the country. (Harper, 10/25)

Stat: The Adult Vaccine Delivery Process Is Becoming A Mess

Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy. If they receive it here, they need to pay out of pocket,” the notice read. (Branswell, 10/25)

CIDRAP: Severe Mental Illness Linked To 50% Increase In COVID-Related Death 

People with severe mental illness (SMI) are at a 50% increased risk of death from all causes following COVID-19 infections, according to a study today in The British Journal of Psychiatry. (Soucheray, 10/25)

The Atlantic: America May Be Missing Out On A Better COVID Treatment

Ensitrelvir, a drug made by the Osaka-based pharmaceutical company Shionogi, was conditionally approved in Japan last November. Like Paxlovid, ensitrelvir works by blocking an enzyme that the SARS-CoV-2 virus uses to clone itself inside the human body. But for the millions of Americans who will likely get COVID in the coming months, the new drug is almost certain to be out of reach. (Gutman-Wei, 10/25)

Also —

The Mercury News: Just Seeing A Sick Person Can Trigger Your Immune System, California Professor Finds

As cold, flu and COVID season sets in, we chatted with Chapman University’s Patricia Lopes, an assistant professor of biology, who studies how sick individuals impact those around them. It’s not as clear-cut as it may seem. Turns out that simply observing a sick individual triggers not only that familiar behavioral response — get away! — but a complex biological response as well. “The really interesting aspect is, it also changes your physiology,” she said. (Sforza, 10/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF